 | • レポートコード：MRC2012B0150 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、乳がん予測遺伝子検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。乳がん予測遺伝子検査の種類別市場規模（高浸透性遺伝子、中浸透性遺伝子、低浸透性遺伝子）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、OncoCyte Corporation、Quest Diagnostics、Thermo Fisher Scientific、Cancer Genetics、PerkinElmer、Invitae、Iverson Genetics、Myriad Genetics、NeoGenomics、 ・地域別グローバル市場分析 2015年-2020年 ・乳がん予測遺伝子検査の北米市場（アメリカ、カナダ、メキシコ） ・乳がん予測遺伝子検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・乳がん予測遺伝子検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・乳がん予測遺伝子検査の南米市場（ブラジル、アルゼンチン） ・乳がん予測遺伝子検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：高浸透性遺伝子、中浸透性遺伝子、低浸透性遺伝子 ・用途別分析：病院、診療所、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Breast Cancer Predictive Genetic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Breast Cancer Predictive Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Breast Cancer Predictive Genetic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Breast Cancer Predictive Genetic Testing market has been segmented into:
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
By Application, Breast Cancer Predictive Genetic Testing has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Breast Cancer Predictive Genetic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Breast Cancer Predictive Genetic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Breast Cancer Predictive Genetic Testing market.
The report offers in-depth assessment of the growth and other aspects of the Breast Cancer Predictive Genetic Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Breast Cancer Predictive Genetic Testing Market Share Analysis
Breast Cancer Predictive Genetic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Breast Cancer Predictive Genetic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Breast Cancer Predictive Genetic Testing sales, revenue and market share for each player covered in this report.
The major players covered in Breast Cancer Predictive Genetic Testing are:
Roche
OncoCyte Corporation
Quest Diagnostics
Thermo Fisher Scientific
Cancer Genetics
PerkinElmer
Invitae
Iverson Genetics
Myriad Genetics
NeoGenomics
Table of Contents
1 Breast Cancer Predictive Genetic Testing Market Overview
1.1 Product Overview and Scope of Breast Cancer Predictive Genetic Testing
1.2 Classification of Breast Cancer Predictive Genetic Testing by Type
1.2.1 Global Breast Cancer Predictive Genetic Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type in 2019
1.2.3 High Penetrant Genes
1.2.4 Intermediate Penetrant Genes
1.2.5 Low Penetrant Genes
1.3 Global Breast Cancer Predictive Genetic Testing Market by Application
1.3.1 Overview: Global Breast Cancer Predictive Genetic Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Breast Cancer Predictive Genetic Testing Market by Regions
1.4.1 Global Breast Cancer Predictive Genetic Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Breast Cancer Predictive Genetic Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Breast Cancer Predictive Genetic Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Breast Cancer Predictive Genetic Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Breast Cancer Predictive Genetic Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Breast Cancer Predictive Genetic Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Breast Cancer Predictive Genetic Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 OncoCyte Corporation
2.2.1 OncoCyte Corporation Details
2.2.2 OncoCyte Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 OncoCyte Corporation SWOT Analysis
2.2.4 OncoCyte Corporation Product and Services
2.2.5 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Quest Diagnostics
2.3.1 Quest Diagnostics Details
2.3.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Quest Diagnostics SWOT Analysis
2.3.4 Quest Diagnostics Product and Services
2.3.5 Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher Scientific SWOT Analysis
2.4.4 Thermo Fisher Scientific Product and Services
2.4.5 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cancer Genetics
2.5.1 Cancer Genetics Details
2.5.2 Cancer Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cancer Genetics SWOT Analysis
2.5.4 Cancer Genetics Product and Services
2.5.5 Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 PerkinElmer
2.6.1 PerkinElmer Details
2.6.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 PerkinElmer SWOT Analysis
2.6.4 PerkinElmer Product and Services
2.6.5 PerkinElmer Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Invitae
2.7.1 Invitae Details
2.7.2 Invitae Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Invitae SWOT Analysis
2.7.4 Invitae Product and Services
2.7.5 Invitae Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 Iverson Genetics
2.8.1 Iverson Genetics Details
2.8.2 Iverson Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Iverson Genetics SWOT Analysis
2.8.4 Iverson Genetics Product and Services
2.8.5 Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 Myriad Genetics
2.9.1 Myriad Genetics Details
2.9.2 Myriad Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Myriad Genetics SWOT Analysis
2.9.4 Myriad Genetics Product and Services
2.9.5 Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 NeoGenomics
2.10.1 NeoGenomics Details
2.10.2 NeoGenomics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 NeoGenomics SWOT Analysis
2.10.4 NeoGenomics Product and Services
2.10.5 NeoGenomics Breast Cancer Predictive Genetic Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Breast Cancer Predictive Genetic Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Breast Cancer Predictive Genetic Testing Players Market Share
3.2.2 Top 10 Breast Cancer Predictive Genetic Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Breast Cancer Predictive Genetic Testing Revenue and Market Share by Regions
4.2 North America Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
4.5 South America Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
5 North America Breast Cancer Predictive Genetic Testing Revenue by Countries
5.1 North America Breast Cancer Predictive Genetic Testing Revenue by Countries (2015-2020)
5.2 USA Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
6 Europe Breast Cancer Predictive Genetic Testing Revenue by Countries
6.1 Europe Breast Cancer Predictive Genetic Testing Revenue by Countries (2015-2020)
6.2 Germany Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
6.3 UK Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
6.4 France Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue by Countries
7.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue by Countries (2015-2020)
7.2 China Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
7.5 India Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
8 South America Breast Cancer Predictive Genetic Testing Revenue by Countries
8.1 South America Breast Cancer Predictive Genetic Testing Revenue by Countries (2015-2020)
8.2 Brazil Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Breast Cancer Predictive Genetic Testing by Countries
9.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Breast Cancer Predictive Genetic Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Breast Cancer Predictive Genetic Testing Market Forecast by Type (2019-2024)
10.3 High Penetrant Genes Revenue Growth Rate (2015-2025)
10.4 Intermediate Penetrant Genes Revenue Growth Rate (2015-2025)
10.5 Low Penetrant Genes Revenue Growth Rate (2015-2025)
11 Global Breast Cancer Predictive Genetic Testing Market Segment by Application
11.1 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2015-2020)
11.2 Breast Cancer Predictive Genetic Testing Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Breast Cancer Predictive Genetic Testing Market Size Forecast (2021-2025)
12.1 Global Breast Cancer Predictive Genetic Testing Market Size Forecast (2021-2025)
12.2 Global Breast Cancer Predictive Genetic Testing Market Forecast by Regions (2021-2025)
12.3 North America Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
12.4 Europe Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
12.6 South America Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Breast Cancer Predictive Genetic Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Breast Cancer Predictive Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Breast Cancer Predictive Genetic Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Breast Cancer Predictive Genetic Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Breast Cancer Predictive Genetic Testing Major Business
Table 7. Roche Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Breast Cancer Predictive Genetic Testing Product and Solutions
Table 10. Roche Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. OncoCyte Corporation Corporate Information, Location and Competitors
Table 12. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Major Business
Table 13. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2018-2019)
Table 14. OncoCyte Corporation SWOT Analysis
Table 15. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product and Solutions
Table 16. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Quest Diagnostics Corporate Information, Location and Competitors
Table 18. Quest Diagnostics Breast Cancer Predictive Genetic Testing Major Business
Table 19. Quest Diagnostics Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 20. Quest Diagnostics SWOT Analysis
Table 21. Quest Diagnostics Breast Cancer Predictive Genetic Testing Product and Solutions
Table 22. Quest Diagnostics Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 24. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Major Business
Table 25. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 26. Thermo Fisher Scientific SWOT Analysis
Table 27. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product and Solutions
Table 28. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cancer Genetics Corporate Information, Location and Competitors
Table 30. Cancer Genetics Breast Cancer Predictive Genetic Testing Major Business
Table 31. Cancer Genetics Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 32. Cancer Genetics SWOT Analysis
Table 33. Cancer Genetics Breast Cancer Predictive Genetic Testing Product and Solutions
Table 34. Cancer Genetics Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. PerkinElmer Corporate Information, Location and Competitors
Table 36. PerkinElmer Breast Cancer Predictive Genetic Testing Major Business
Table 37. PerkinElmer Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 38. PerkinElmer SWOT Analysis
Table 39. PerkinElmer Breast Cancer Predictive Genetic Testing Product and Solutions
Table 40. PerkinElmer Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Invitae Corporate Information, Location and Competitors
Table 42. Invitae Breast Cancer Predictive Genetic Testing Major Business
Table 43. Invitae Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 44. Invitae SWOT Analysis
Table 45. Invitae Breast Cancer Predictive Genetic Testing Product and Solutions
Table 46. Invitae Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Iverson Genetics Corporate Information, Location and Competitors
Table 48. Iverson Genetics Breast Cancer Predictive Genetic Testing Major Business
Table 49. Iverson Genetics Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 50. Iverson Genetics SWOT Analysis
Table 51. Iverson Genetics Breast Cancer Predictive Genetic Testing Product and Solutions
Table 52. Iverson Genetics Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Myriad Genetics Corporate Information, Location and Competitors
Table 54. Myriad Genetics Breast Cancer Predictive Genetic Testing Major Business
Table 55. Myriad Genetics Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 56. Myriad Genetics SWOT Analysis
Table 57. Myriad Genetics Breast Cancer Predictive Genetic Testing Product and Solutions
Table 58. Myriad Genetics Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. NeoGenomics Corporate Information, Location and Competitors
Table 60. NeoGenomics Breast Cancer Predictive Genetic Testing Major Business
Table 61. NeoGenomics Breast Cancer Predictive Genetic Testing Total Revenue (USD Million) (2017-2018)
Table 62. NeoGenomics SWOT Analysis
Table 63. NeoGenomics Breast Cancer Predictive Genetic Testing Product and Solutions
Table 64. NeoGenomics Breast Cancer Predictive Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) by Players (2015-2020)
Table 66. Global Breast Cancer Predictive Genetic Testing Revenue Share by Players (2015-2020)
Table 67. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Regions (2015-2020)
Table 69. North America Breast Cancer Predictive Genetic Testing Revenue by Countries (2015-2020)
Table 70. North America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 71. Europe Breast Cancer Predictive Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Breast Cancer Predictive Genetic Testing Revenue by Countries (2015-2020)
Table 74. South America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Table 77. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) by Type (2015-2020)
Table 78. Global Breast Cancer Predictive Genetic Testing Revenue Share by Type (2015-2020)
Table 79. Global Breast Cancer Predictive Genetic Testing Revenue Forecast by Type (2021-2025)
Table 80. Global Breast Cancer Predictive Genetic Testing Revenue by Application (2015-2020)
Table 81. Global Breast Cancer Predictive Genetic Testing Revenue Share by Application (2015-2020)
Table 82. Global Breast Cancer Predictive Genetic Testing Revenue Forecast by Application (2021-2025)
Table 83. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Breast Cancer Predictive Genetic Testing Picture
Figure 2. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type in 2019
Figure 3. High Penetrant Genes Picture
Figure 4. Intermediate Penetrant Genes Picture
Figure 5. Low Penetrant Genes Picture
Figure 6. Breast Cancer Predictive Genetic Testing Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Breast Cancer Predictive Genetic Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Breast Cancer Predictive Genetic Testing Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Breast Cancer Predictive Genetic Testing Revenue Market Share in 2019
Figure 19. Global Top 10 Players Breast Cancer Predictive Genetic Testing Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Regions (2015-2020)
Figure 23. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Regions in 2018
Figure 24. North America Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 25. Europe Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 27. South America Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 29. North America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 30. North America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019
Figure 31. USA Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 32. Canada Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 34. Europe Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019
Figure 36. Germany Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 37. UK Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 38. France Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 39. Russia Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 40. Italy Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019
Figure 43. China Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 44. Japan Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 45. Korea Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 46. India Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 48. South America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 49. South America Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019
Figure 50. Brazil Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 55. UAE Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Breast Cancer Predictive Genetic Testing Revenue and Growth Rate (2015-2020)
Figure 58. Global Breast Cancer Predictive Genetic Testing Revenue Share by Type (2015-2020)
Figure 59. Global Breast Cancer Predictive Genetic Testing Revenue Share by Type in 2019
Figure 60. Global Breast Cancer Predictive Genetic Testing Market Share Forecast by Type (2021-2025)
Figure 61. Global High Penetrant Genes Revenue Growth Rate (2015-2020)
Figure 62. Global Intermediate Penetrant Genes Revenue Growth Rate (2015-2020)
Figure 63. Global Low Penetrant Genes Revenue Growth Rate (2015-2020)
Figure 64. Global Breast Cancer Predictive Genetic Testing Revenue Share by Application (2015-2020)
Figure 65. Global Breast Cancer Predictive Genetic Testing Revenue Share by Application in 2019
Figure 66. Global Breast Cancer Predictive Genetic Testing Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Breast Cancer Predictive Genetic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Breast Cancer Predictive Genetic Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
Figure 74. Europe Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
Figure 76. South America Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Breast Cancer Predictive Genetic Testing Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
遺伝子検査の世界市場（～2026年） Genetic testing, also known as DNA testing, allows the determination of bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. In agriculture, a form of genetic testing known as progeny testing can be used to evaluate the quality of breeding stock. In population ecology, gene…- 遺伝子検査サービスの世界市場（～2026年） Genetic test is a type of medical test which analyzes the changes in chromosomes, proteins, or genes, which may be caused by any suspected genetic condition or disease. Market Analysis and Insights: Global Genetic Testing Services Market The global Genetic Testing Services market size is projected t…
- ポイントオブケア遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Point-of-Care Genetic Testing Market The global Point-of-Care Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Point-of-Care Genetic Testing Scope and Market Size Poi…
- 出生前遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Prenatal Genetic Testing Market The global Prenatal Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prenatal Genetic Testing Scope and Market Size Prenatal Genetic T…
- 妊娠前遺伝子検査の世界市場（～2026年） Market Analysis and Insights: Global Pre-Pregnancy Genetic Testing Market The global Pre-Pregnancy Genetic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pre-Pregnancy Genetic Testing Scope and Market Size Pre…